Cure8 research brief
This study suggests a plant extract might boost ketone-body levels and reduce colitis-like inflammation in a mouse model — a concept that could inform future dietary or therapeutic research for ulcerative colitis but is not yet applicable to patient care.
Researchers studying diet, ketogenesis, or novel therapeutics for IBD; clinicians interested in emerging preclinical research on diet-related interventions; patients curious about diet and complementary approaches (with the caveat this is preclinical).
A recent preclinical study in mice tested extracts of Rehmannia glutinosa (a traditional medicinal/edible plant) and found the extract increased ketone-body levels and, when given to mice with dextran sulfate sodium (DSS)–induced colitis, reduced measures of intestinal inflammation and oxidative injury compared with controls.
The authors report DH increased activity of enzymes linked to ketogenesis (e.g., BDH1, HMGCS2) and suggest effects may involve suppression of the STAT3 pathway. The study compares the plant extract’s effects with a ketogenic diet and reports similar protective effects in this mouse model. Safety was assessed in mice via hepatic and renal function markers.
This is an animal (mouse) study reported as a journal article abstract. It suggests the plant extract has ketogenic and anti‑inflammatory effects in mice, but it does not provide clinical evidence in people with ulcerative colitis. It does not establish dosing, efficacy, or safety in humans and should not be interpreted as medical advice.
Findings are from an animal model (DSS-induced colitis in mice) reported in a journal abstract; animal results often do not translate directly to humans. The abstract reports biochemical and pathway data (enzymes, STAT3) but no clinical trial data. Consult clinicians before making changes to diet or using herbal extracts.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The authors declare no conflicts of interest.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The study identifies a specific polysaccharide fraction (VPS-30) that reduced inflammation and improved gut barrier markers in cell and mouse models of colitis, suggesting a possible new functional-food lead for...
The findings suggest a processed herbal/tea preparation may alter gut metabolites and microbes to reduce colitis in mice, which could guide future dietary or translational research relevant to people with ulcerative...
This animal study suggests Antarctic krill oil may reduce inflammation and weight loss in a mouse model of ulcerative colitis and works alongside changes in gut microbiota and metabolites—findings that could inform...
